Blood test may track ALS progression, speed diagnosis
A new blood test that analyzes tiny fragments of DNA released by dying cells may help diagnose amyotrophic lateral sclerosis…
Articles by Marisa Wexler, MS
ALS and MS have very strong geographic association, study finds
Amyotrophic lateral sclerosis (ALS) is more common in some parts of the U.S. than others, and it has a…
Diabetes adds greater risk of mobility loss in ALS: Study
People with amyotrophic lateral sclerosis (ALS) who also have diabetes tend to lose the ability to walk faster than…
ALS therapy EKZ-102 on track to enter clinical testing in 2026
EKZ-102, Eikonizo Therapeutics‘s experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical…
Pridopidine Phase 3 trial to start enrolling early next year
A pivotal Phase 3 clinical trial testing the oral therapy pridopidine in people with amyotrophic lateral sclerosis (ALS)…
Is ALS an autoimmune disease? New evidence says maybe yes.
In a new study by a team of U.S. scientists, a group of inflammatory immune cells was found to mistakenly…
Scientists are analyzing hair to develop a new ALS diagnostic test
Analyzing single strands of hair has shown researchers that the dynamics of certain metal molecules, such as copper and zinc,…
Blood test could diagnose ALS years before symptoms appear: Study
Through analyses of blood samples from hundreds of patients, researchers have developed a highly accurate test for diagnosing amyotrophic…
Promising BCI tech can translate thoughts to speech for ALS patients
New research is bringing mind-to-speech technology a step closer to reality for people with paralysis, including those with amyotrophic…
This year’s ALS Nexus conference celebrated progress, shared hope
The second edition of ALS Nexus — a conference hosted earlier this month in Dallas by the ALS…